SciClone Pharmaceuticals (Holdings) Limited (HK:6600) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
SciClone Pharmaceuticals (Holdings) Limited has disclosed its Board of Directors, comprising executive, non-executive, and independent members, with ZHAO Hong as CEO and PAN Rongrong as CFO. The company has established three board committees—Audit, Remuneration, and Nomination—with specific directors allocated to each as members or chairpersons, ensuring governance and oversight.
For further insights into HK:6600 stock, check out TipRanks’ Stock Analysis page.